Giuseppe Curigliano Selected Research

Giuseppe Curigliano Research Topics

Disease

238	Neoplasms (Cancer) 12/2024 - 03/2003
221	Breast Neoplasms (Breast Cancer) 05/2024 - 09/2002
43	Triple Negative Breast Neoplasms 03/2024 - 01/2013
24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 05/2002
20	Disease Progression 05/2024 - 05/2007
15	Neoplasm Metastasis (Metastasis) 11/2023 - 09/2002
11	Melanoma (Melanoma, Malignant) 01/2024 - 08/2013
11	Cardiotoxicity 09/2022 - 09/2010
10	Microsatellite Instability 01/2022 - 01/2017
8	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 04/2013
8	COVID-19 01/2022 - 01/2020
8	Prostatic Neoplasms (Prostate Cancer) 02/2021 - 05/2007
6	Stomach Neoplasms (Stomach Cancer) 11/2023 - 09/2007
5	Carcinogenesis 06/2023 - 12/2016
5	Brain Neoplasms (Brain Tumor) 01/2023 - 11/2017
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 02/2013
5	Lung Neoplasms (Lung Cancer) 03/2022 - 07/2003
5	Carcinoma (Carcinomatosis) 01/2022 - 03/2005
5	Heart Failure 01/2018 - 09/2010
4	Circulating Neoplastic Cells 01/2024 - 10/2010
4	Thyroid Neoplasms (Thyroid Cancer) 11/2023 - 01/2021
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2022 - 03/2020
4	Pain (Aches) 01/2018 - 09/2007
3	Pathologic Complete Response 12/2023 - 03/2020
3	Inflammatory Breast Neoplasms 11/2023 - 01/2018
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 12/2021
3	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 09/2017

Drug/Important Bio-Agent (IBA)

56	Biomarkers (Surrogate Marker)IBA 05/2024 - 09/2007
54	Hormones (Hormone)IBA 05/2024 - 10/2004
32	Immune Checkpoint InhibitorsIBA 01/2024 - 03/2014
31	Trastuzumab (Herceptin)FDA Link 12/2023 - 01/2006
27	Immunoconjugates (Immunoconjugate)IBA 05/2024 - 01/2019
25	Estrogen ReceptorsIBA 05/2024 - 10/2004
24	human ERBB2 proteinIBA 12/2023 - 11/2013
20	ErbB Receptors (EGF Receptor)IBA 02/2024 - 12/2004
16	VaccinesIBA 01/2024 - 09/2007
14	AntigensIBA 02/2024 - 10/2009
13	Phenobarbital (Luminal)FDA Link 05/2024 - 10/2012
13	trastuzumab deruxtecanIBA 05/2024 - 12/2021
13	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 06/2004
11	Proteins (Proteins, Gene)FDA Link 02/2023 - 03/2003
9	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2024 - 01/2020
9	palbociclibIBA 02/2024 - 01/2019
9	Biosimilar PharmaceuticalsIBA 01/2023 - 09/2014
9	COVID-19 VaccinesIBA 01/2022 - 01/2021
9	AnthracyclinesIBA 11/2021 - 06/2015
8	AntibodiesIBA 01/2024 - 08/2013
8	Monoclonal AntibodiesIBA 01/2023 - 09/2010
8	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 09/2004
8	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 03/2003
7	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 12/2006
7	sacituzumab govitecanIBA 11/2023 - 01/2020
7	Ado-Trastuzumab EmtansineIBA 11/2023 - 01/2018
7	Cancer VaccinesIBA 01/2022 - 09/2007
7	Tyrosine Kinase InhibitorsIBA 11/2021 - 09/2010
7	Gefitinib (Iressa)FDA Link 01/2021 - 02/2005
6	Circulating Tumor DNAIBA 02/2024 - 06/2014
6	pembrolizumabIBA 10/2023 - 01/2019
6	atezolizumabIBA 09/2023 - 01/2019
6	AlpelisibIBA 01/2023 - 08/2018
6	Neoplasm Antigens (Tumor Antigens)IBA 11/2015 - 12/2007
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 09/2012
5	NivolumabIBA 01/2024 - 01/2020
5	Cyclin-Dependent Kinase 4IBA 12/2023 - 11/2017
5	pralsetinibIBA 11/2023 - 01/2021
5	ribociclibIBA 09/2023 - 05/2017
5	LigandsIBA 06/2023 - 02/2015
5	PlatinumIBA 01/2023 - 03/2005
5	tucatinibIBA 01/2023 - 01/2020
5	Capecitabine (Xeloda)FDA Link 01/2023 - 06/2015
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2024 - 05/2017
4	Peptides (Polypeptides)IBA 05/2024 - 09/2007
4	Methotrexate (Mexate)FDA LinkGeneric 01/2024 - 09/2002
4	IpilimumabIBA 01/2024 - 08/2013
4	Aromatase InhibitorsIBA 03/2023 - 10/2019
4	B7-H1 AntigenIBA 01/2023 - 01/2019
4	taxaneIBA 01/2023 - 03/2005
4	CTLA-4 AntigenIBA 09/2022 - 11/2013
4	pertuzumabIBA 08/2022 - 01/2018
3	abemaciclibIBA 05/2024 - 01/2019
3	Docetaxel (Taxotere)FDA Link 12/2023 - 01/2017
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2023 - 05/2007
3	margetuximabIBA 10/2023 - 01/2021
3	Phosphotransferases (Kinase)IBA 06/2023 - 05/2014
3	Epidermal Growth Factor (EGF)IBA 03/2023 - 10/2012
3	Transaminases (Aminotransferases)IBA 01/2023 - 03/2005
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2021 - 11/2015

Therapy/Procedure

128	Therapeutics 12/2024 - 06/2004
71	Drug Therapy (Chemotherapy) 04/2024 - 05/2002
39	Immunotherapy 01/2024 - 09/2007
17	Neoadjuvant Therapy 02/2024 - 01/2013
15	Precision Medicine 01/2023 - 01/2014
14	Radiotherapy 02/2024 - 03/2004
13	Adjuvant Chemotherapy 01/2024 - 01/2013
6	Mastectomy (Mammectomy) 11/2023 - 03/2004
6	Catheters 10/2009 - 11/2002
4	Segmental Mastectomy (Lumpectomy) 12/2023 - 03/2004
4	Breast Implants (Breast Implant) 12/2022 - 03/2020
4	Aftercare (After-Treatment) 01/2022 - 12/2004
4	Mammaplasty (Breast Reconstruction) 10/2015 - 08/2011